William Blair & Company
LABU icon

William Blair & Company’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

William Blair & Company’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5
Closed -$491 – 1839
2023
Q1 		$491 Hold
5
– – ﹤0.01% 1795
2022
Q4 		$707 Buy
+5
New +$697 ﹤0.01% 1803

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

William Blair & Company's LABU Position: Q2 2023 in Review

William Blair & Company sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2023, closing a stake of 5 shares — an estimated $491 sold.

William Blair & Company first reported a position in LABU in Q4 2022 and held it in 2 quarters. The position peaked at $707 in Q4 2022. 51 funds tracked by Wall St. Rank hold LABU as of Q2 2023.

  • William Blair & Company reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2023 after selling out during the quarter.
  • William Blair & Company sold 5 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2023, an estimated $491.
  • William Blair & Company first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 2 quarters.
  • William Blair & Company's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $707 in Q4 2022.
  • 51 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2023.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.